---

Cancer Types

Types of Cancer > Breast Cancer > Conferences

Conferences

OncoLink at ASTRO 2009

Ten-year Results of a Randomized Trial of Internal Mammary Chain Irradiation after Mastectomy

OncoLink at ASCO 2009

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

OncoLink at the San Antonio Breast Cancer Symposium 2008

Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists’ group (BOOG)

OncoLink at ASTRO 2008

Acupuncture for the Treatment of Vasomotor Symptoms in Breast Cancer Patients Receiving Hormone Suppression Treatment

OncoLink at ASCO 2008

Adjuvant ovarian suppression combined with tamoxifen or anastrazole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive, stage I and II breast cancer: First efficacy results from ABCSG

OncoLink at ASTRO 2007

Breast Cancer After Supradiaphragmatic Irradiation for Hodgkin's Disease; Risk Analysis and Possible Surveillance Strategies

OncoLink at ASCO 2007

The cognitive effects of modafinil in breast cancer survivors: A randomized clinical trial

OncoLink at the San Antonio Breast Cancer Symposium 2006

Axillary lymph node nanometastases are prognostic factors for metastatic relapse in breast cancer patients

OncoLink at ASTRO 2006

The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance"

OncoLink at ASCO 2006

Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831

OncoLink at the Chemotherapy Foundation Symposium 2005

Hormonal Therapies in Breast Cancer

OncoLink at ASTRO 2005

ASTRO 2005 Breast Cancer Highlights

OncoLink at ASCO 2005

BIG 1-98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for post-menopausal women with receptor-positive breast cancer.

OncoLink at ASTRO 2004

Breast Cancer Patients Attitudes Towards Clinical Trials in the Radiation Oncology Clinic Versus Those Searching for Trial Information on the Internet

OncoLink at ASCO 2004

Cognitive function, fatigue and menopausal symptoms in women following adjuvant chemotherapy for breast cancer: One and two year follow-up of a prospective controlled study

OncoLink at the Chemotherapy Foundation Symposium 2003

Adding Carboplatin to Trastuzumab/Paclitaxel in Her2+ Breast Cancer: An Update

OncoLink at ASTRO 2003

Analysis of Local Failure After Breast Conserving Therapy for Locally Advanced Breast Cancer

OncoLink at ASCO 2003

Chemohormonal therapy in premenopausal node-positive, receptor positive breast cancer: An Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT 0101)

OncoLink at ASTRO 2002

Accelerated Partial Breast Irradiation Via Interstitial Brachytherapy as the Sole Radiation Modality for Treatment of Early-Stage Breast Cancer

OncoLink at ASCO 2002

Efficacy and Tolerability of Two Dosing Regimens of R115777 (Zarnestra), a Farnesyl Protein Transferase Inhibitor, in Patients with Advanced Breast Cancer

OncoLink at ASTRO 2001

Locoregional Failure of Post-Mastectomy Patients Who Had 1-3 Positive Axillary Lymph Nodes without Adjuvant Radiotherapy

OncoLink at ASCO 2001

Clinical Significance Of Axillary Micrometastases In Breast Cancer: How Small Is Too Small?

OncoLink at ASCO 2000

3 Versus 6 Cycles of CMF in Breast Cancer Patients with 1 to 9 Positive Nodes: Results of the German Adjuvant Breast Cancer Group (GABG) III Trial

OncoLink at ASTRO 2000

Black and White Patients Fare Equally Well When Treated with Post-lumpectomy Radiotherapy

OncoLink at ASCO 1999

First Independent Assessment of Breast Cancer Risk Reduction Drugs Supports a Role for Tamoxifen Therapy

OncoLink at ASTRO 1999

Energy and intensity modulated electron beams for treatment of breast cancer

OncoLink at ASCO 1998

CAF Slightly Improves Survival for High-Risk Localized Breast Cancer Patients

OncoLink at ASCO 1996

Optimal Timing of Breast Cancer Surgery Within Menstrual Cycle